Dmitry Samarsky

First Name*

Last Name*

Email*

Phone*

Message*

I am authorized to claim this profile. I agree Eventually may contact me regarding my request.

Your request has been received.
Thank you.

Oops! Something went wrong while submitting the form.

First Name*

Last Name*

Email*

Phone*

Message*

Dmitry Samarsky and Eventually may contact me regarding my request.

Your request has been received.
Thank you.

Oops! Something went wrong while submitting the form.

Contact Dmitry

Dmitry Samarsky

Chief Technology Officer

Sirnaomics, Inc.

Dmitry Samarsky has been at the inception of RNAi technology and drug development - starting in 2001 as Director of Technology Development at Sequitur (acquired by Invitrogen) and (in 2005) as Director of Technology Development at Dharmacon (now part

Talks About
#drugdevelopment #biomedical #Pharmaceuticals

Preferred Locations
#NorthAmerica

Speaking Engagements

Oligonucleotide Therapeutics and Delivery

Paid

Oligonucleotide Therapeutics - the emerging medicine class - are harnessing the therapeutic benefit of targeting genetic material utilising oligonucleotide conjugates, antisense oligonucleotides (ASOs), mRNA and RNAi.

21-22 September 2022

Healthcare

14th Annual RNA Therapeutics Conference

Paid

SAE Media Group is proud to announce the 14th Annual RNA Therapeutics Conference taking place on 8-9 February 2023 RNA therapeutics is a rapidly expanding industry with increasingly growing potential for immunotherapy, personalised medicines, and treatment of genetic, infectious and chronic diseases.

08-09 February 2023

Healthcare

Claim Your Profile Request

Speaker Contact Request

SPEAKER

Dmitry Samarsky

Chief Technology Officer

Speaking Engagements

Oligonucleotide Therapeutics and Delivery

14th Annual RNA Therapeutics Conference